Increased frequency of dosing of imiquimod 5% cream in the treatment of external genital warts in women

International Journal of Gynecology and Obstetrics

Volumn 76, Issue 2, 2002, Pages 191-193

  Trofatter Jr, K F ^a   Ferenczy, A ^b   Fife, K H ^c  

^a UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

External genital warts; Female; Imiquimod 5 cream; Immune response modifier; Treatment

Indexed keywords

IMIQUIMOD;

ARTICLE; CLINICAL TRIAL; CONDYLOMA; CREAM; DOSE RESPONSE; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; GENITAL SYSTEM; HUMAN; PRIORITY JOURNAL; TISSUE REACTION; TREATMENT OUTCOME;

EID: 0036152592     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(01)00573-2     Document Type: Article

References (1)

1. Self-administered topical 5% imiquimod cream for external anogenital warts